{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:30:09Z","timestamp":1790807409505,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There have been controversial findings from recent studies regarding anthracyclines use and the subsequent risk of arrhythmias. This study aimed to evaluate the existing evidence of the risk of arrhythmias in patients treated with anthracyclines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, Scopus, and Web of Science databases were searched up to April 2022 using keywords such as \u201canthracycline\u201d and \u201carrhythmia.\u201d Dichotomous data were presented as relative risk (RR) and confidence interval (CI), while continuous data were presented as mean difference (MD) and CI. Revman software version 5.4 was used for the analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thirteen studies were included with a total of 26891 subjects. Pooled analysis showed that anthracyclines therapy was significantly associated with a higher risk of arrhythmia (RR: 1.58; 95% CI: 1.41\u20131.76; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .00001), ST segment and T wave abnormalities (RR: 1.73, 95% CI: 1.18\u20132.55, <jats:italic toggle=\"yes\">P<\/jats:italic> = .005), conduction abnormalities and AV block (RR = 1.86, 95% CI = 1.06\u20133.25, <jats:italic toggle=\"yes\">P<\/jats:italic> = .03), and tachycardia (RR: 1.736, 95% CI: 1.11\u20132.69, <jats:italic toggle=\"yes\">P<\/jats:italic> = .02). Further analyses of the associations between anthracyclines and atrial flutter (RR = 1.30, 95% CI = 0.29\u20135.89, <jats:italic toggle=\"yes\">P<\/jats:italic> = .74), atrial ectopic beats (RR: 1.27, 95% CI: 0.78\u20132.05, <jats:italic toggle=\"yes\">P<\/jats:italic> = .34), and ventricular ectopic beats (RR: 0.93, 95% CI: 0.53\u20131.65, <jats:italic toggle=\"yes\">P<\/jats:italic> = .81) showed no statistically significant results. Higher doses of anthracycline were associated with a higher risk of arrhythmias (RR: 1.49; 95% CI: 1.08\u20132.05; <jats:italic toggle=\"yes\">P<\/jats:italic> = .02) compared to the lower doses (RR: 1.36; 95% CI: 1.00\u20131.85; <jats:italic toggle=\"yes\">P<\/jats:italic> = .05). Newer generations of Anthracycline maintained the arrhythmogenic properties of previous generations, such as Doxorubicin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Anthracyclines therapy was significantly associated with an increased risk of arrhythmias. Accordingly, Patients treated with anthracyclines should be screened for ECG abnormalities and these drugs should be avoided in patients susceptible to arrhythmia. The potential benefit of the administration of prophylactic anti-fibrotic and anti-arrhythmic drugs should also be explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035770","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:28:34Z","timestamp":1701163714000},"page":"e35770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Anthracyclines and the risk of arrhythmias: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"102","author":[{"given":"Yomna E.","family":"Dean","sequence":"first","affiliation":[{"name":"Alexandria Medical Center (AMC), Alexandria University, Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Dahshan","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam R.","family":"Motawea","sequence":"additional","affiliation":[{"name":"Alexandria Medical Center (AMC), Alexandria University, Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Tanas","sequence":"additional","affiliation":[{"name":"Alexandria Medical Center (AMC), Alexandria University, Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Rakha","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Hasan","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kishk","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elsayed","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdelkader","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Sapporo Medical University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Beni Suef University, Faculty of Medicine, Beni Suef, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Helmy","sequence":"additional","affiliation":[{"name":"Kharkiv National Medical University, Kharkiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan H.","family":"Elhalag","sequence":"additional","affiliation":[{"name":"Alexandria Medical Center (AMC), Alexandria University, Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad Moheyeldin","family":"Farghaly","sequence":"additional","affiliation":[{"name":"Badr University, College of Medicine, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Khalid Samir","family":"Abdelkader","sequence":"additional","affiliation":[{"name":"Port Said University, Faculty of Medicine, Port Said, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-218X","authenticated-orcid":false,"given":"Jaffer","family":"Shah","sequence":"additional","affiliation":[{"name":"Kateb University, Medical Research Center, Kabul, Afghanistan"},{"name":"Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa","family":"Hakim","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"},{"name":"Harvard Medical School, Boston, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Aiash","sequence":"additional","affiliation":[{"name":"Suez Canal University, Faculty of Medicine, Ismailia, Egypt"},{"name":"SUNY Upstate Medical University, Syracuse, US."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"104542","DOI":"10.1016\/j.phrs.2019.104542","article-title":"Doxorubicin and its proarrhythmic effects: a comprehensive review of the evidence from experimental and clinical studies.","volume":"151","author":"Benjanuwattra","year":"2020","journal-title":"Pharmacol Res"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4330\/wjc.v13.i1.28","article-title":"Anthracycline-induced cardiotoxicity: a case report and review of literature.","volume":"13","author":"Chong","year":"2021","journal-title":"World J Cardiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects.","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin cardiomyopathy.","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00392-018-1386-0","article-title":"Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.","volume":"108","author":"Ohtani","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.smj.0000257382.89910.fe","article-title":"Early and late arrhythmogenic effects of doxorubicin.","volume":"100","author":"Kilickap","year":"2007","journal-title":"South Med J"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/europace\/eum033","article-title":"Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.","volume":"9","author":"Rudzinski","year":"2007","journal-title":"Europace"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/1097-0142(197911)44:5<1588::AID-CNCR2820440508>3.0.CO;2-X","article-title":"Sudden death during doxorubicin administration.","volume":"44","author":"Wortman","year":"1979","journal-title":"Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/europace\/eup300","article-title":"Introducing a new entity: chemotherapy-induced arrhythmia.","volume":"11","author":"Guglin","year":"2009","journal-title":"Europace"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jjcc.2020.10.007","article-title":"Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity.","volume":"77","author":"Kinoshita","year":"2021","journal-title":"J Cardiol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"R15-20250504","first-page":"CD005006","article-title":"Different anthracycline derivates for reducing cardiotoxicity in cancer patients.","volume":"2010","author":"van Dalen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.amjcard.2016.07.049","article-title":"Prognostic significance of new-onset atrial fibrillation in patients with non-hodgkin\u2019s lymphoma treated with anthracyclines.","volume":"118","author":"Amioka","year":"2016","journal-title":"Am J Cardiol"},{"key":"R17-20250504","first-page":"1003","article-title":"Cardiac effects of anthracycline treatment and their implications for aeromedical certification.","volume":"74","author":"Evans","year":"2003","journal-title":"Aviat Space Environ Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-019-0298-6","article-title":"Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials.","volume":"20","author":"Ma","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"100575","DOI":"10.1016\/j.cophys.2022.100575","article-title":"Cardiac fibrosis in oncologic therapies.","volume":"29","author":"Packard","year":"2022","journal-title":"Curr Opin Physiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/ars.2021.0002","article-title":"Anthracycline-induced atrial structural and electrical remodeling characterizes early cardiotoxicity and contributes to atrial conductive instability and dysfunction.","volume":"37","author":"Tan","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12185-009-0461-8","article-title":"Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin\u2019s lymphoma: single center, 15-year experience.","volume":"91","author":"Zhai","year":"2010","journal-title":"Int J Hematol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1002\/cncr.24621","article-title":"Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer [published correction appears in Cancer 2009 Dec 15;115(24):5849-51].","volume":"115","author":"Du","year":"2009","journal-title":"Cancer"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.annonc.a058795","article-title":"Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.","volume":"5","author":"Valagussa","year":"1994","journal-title":"Ann Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/bja\/aeh132","article-title":"Is prolongation of the QTc interval during isoflurane anaesthesia more prominent in women pretreated with anthracyclines for breast cancer?","volume":"92","author":"Owczuk","year":"2004","journal-title":"Br J Anaesth"},{"key":"R25-20250504","article-title":"Disturbed cardiac rhythm as a manifestation of cardiotoxicity of individual doses of anthracycline cytostatics.","volume":"5","author":"Kov\u010din","year":"1999","journal-title":"Med Sci Monit"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2007.11.8877","article-title":"Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest oncology group protocol s8897.","volume":"26","author":"Ganz","year":"2008","journal-title":"J Clin Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V","article-title":"Acute arrhythmogenicity of doxorubicin administration.","volume":"60","author":"Steinberg","year":"1987","journal-title":"Cancer"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00280-011-1614-z","article-title":"Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.","volume":"68","author":"Lebedinsky","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R29-20250504","first-page":"71","article-title":"The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study.","volume":"38","author":"Liu","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"e010101","DOI":"10.1161\/JAHA.118.010101","article-title":"Incidence of cancer treatment-induced arrhythmia associated with novel targeted chemotherapeutic agents.","volume":"7","author":"Nickel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.egja.2013.08.003","article-title":"Effect of anthracyclines and isoflurane on QTc interval.","volume":"30","author":"Venugopal","year":"2014","journal-title":"Egypt J Anaesth"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jelectrocard.2020.04.024","article-title":"Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy.","volume":"60","author":"Chen","year":"2020","journal-title":"J Electrocardiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ajh.26230","article-title":"Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.","volume":"96","author":"Boddicker","year":"2021","journal-title":"Am J Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:03:21Z","timestamp":1746345801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":32,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035770","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}